Pharma executives point blame of soaring drug costs on PBMs
Pharmaceutical companies say they will not make a commitment to lowering the list price of prescription drugs, but they all said they would support some administration proposals to reform the healthcare system. Executives from seven top drug companies testified before Congress Tuesday. Anna Werner reports.